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Abstract: In our previous study the enrichment of the intestinal proteome of type 1 diabetes (T1D)
children with Bacteroides proteins was observed, which led us to our current study that aimed to
isolate and characterize Bacteroides species from fecal samples of T1D and control children. Repetitive
sequence-based PCR (rep-PCR) was used for typing the isolated Bacteroides species. The antibiotic
susceptibility and mucinolytic activity of the isolates was determined. The quantification of specific
bacterial groups in the fecal samples was determined by qPCR. The ability to adhere and invade
the human colonic cell line HT29-MTX-E12 of strains of P. dorei, B. uniformis and P. distasonis was
determined and their whole genome sequencing was performed. The results showed similar numbers
of Bacteroides species in T1D and control samples, but unique Bacteroides species and a higher recovery
of P. distasonis from T1D samples was observed. Rep-PCR grouped the different Bacteroides species, but
no discrimination by origin was achieved. T1D children showed a significant increase in Proteobacteria
and a depletion in Lactobacillus sp. All tested P. dorei, B. uniformis and P. distasonis were able to adhere
to HT29-MTX-E12 cells but significant differences (p < 0.05) in the ability to invade was observed.
The highest ability to invade was exhibited by P. distasonis PtF D14MH1 and P. dorei PtFD16P1, while
B. uniformis strains were unable to invade. The damage to tight junctions was also observed. The
presence of Lactobacillus sp. inhibited the invasion ability of P. distasonis PtF D14MH1 but not P. dorei
PtFD16P1. Sequences of agonist peptides of the human natural preproinsulin and the insulin B chain
insB:9-23 peptide mimics were identified. The results reported in our study stresses the continued
efforts required to clarify the link between T1D and gut microbiota.
Keywords: type 1 diabetes; Phocaeicola dorei; Parabacteroides distasonis; Bacteroides uniformis; invasion;
phage; molecular mimicry
1. Introduction
Type 1 diabetes (T1D) is characterized by a gradual pancreatic β-cell destruction
culminating with insulin deficiency causing a hyperglycemic state, which in the medium-
to long-term will cause vascular damage (neuropathy), affecting vision (retinopathy) and
kidney function (nephropathy). The burden of genetic heritage in T1D is well recognized.
However, the increase in incidence cannot be explained only by a genetic boost. The
probability that environmental factors contribute to trigger the disease is currently gaining
broader acceptance [1,2]. Among the environmental factors that may be implicated in this
triggering event are the exposure of genetic susceptible individuals at early age to gluten
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containing food, viral upper respiratory tract infections, and exposure to deficient innate
immune activator [3–6].
The disturbance of the gut microbiome in children at risk of developing T1D has been
extensively investigated worldwide [7–16]. In contrast the microbiome of children with
established diabetes is still poorly studied [7,14,17–20]. In the study of Alkanani et al. [7]
the gut microbiome of new-onset patients and seropositive subjects from USA with two to
four autoantibodies showed a higher (p = 0.01) median percentage abundance of Bacteroides
(35.62%) (21 subjects in the group of new-onset patients, and 16 in the seropositive group)
in comparison with individuals with just one autoantibody (6.37), (12 subjects in the new-
onset patients group, and five in the seropositive group). Additionally, De Goffau et al. [21]
reported higher abundance of the genus Bacteroides in children with β-cell autoimmunity
who participated in the Finnish Dietary Intervention trial for Prevention of Type 1 Diabetes
(FINDIA), and the Trial to Reduce IDMM in the Genetically at Risk (TRIGR) studies per-
formed in Finland. The study conducted by Murri et al. [17] showed that Spanish children
with established T1D carried more Bacteroidetes in comparison with healthy children. The
higher abundance of sequences belonging to Bacteroides in the gut of Spanish children
with T1D was also reported in the study of Leiva-Gea et al. [20], where they observed an
enrichment of 72.21% in T1D cases in contrast to healthy controls that reached 58.45%.
Geographical factors may considerably influence the gut microbiome [12]. For exam-
ple, in Finland, in the city of Turku, it was reported that Bacteroides dorei (currently classified
as Phocaeicola dorei [22]), dominates the gut of children at risk of developing T1D [8],
whereas in the cities of Tampere and Oulu the increase of B. dorei was not observed [23].
Instead, these authors observed a dominant OTU, grouping B. dorei and B. vulgatus, that
were inversely associated with following islet autoimmunity. Furthermore, in their study
another Bacteroides sp., B. caccae was inversely associated with islet autoimmunity [23].
The control children in the Cinek et al. study [23] were enriched with an OTU assigned to
Bifidobacterium bifidum. Another example of geographical differences regarding the compo-
sition of T1D children microbiome is the study conducted in the Northern area of China
where children newly diagnosed with T1D (<6 months) showed an intestinal microbiota
enriched with the genus Blautia that was also correlated with the levels of HbA1c, T1D
autoantibodies, and titers of tyrosine phosphatase autoantibodies (IA-2) [19]. Furthermore,
in the study of Kostic et al. [13] it was reported that the abundance of the genus Blautia was
correlated with serum glucose levels in children with T1D.
Portuguese children with established T1D showed a metaproteome enriched with
proteins originated from Eubacterium rectale (currently Agathobacter rectalis), Faecalibacterium
prausnitzii, B. dorei and B. uniformis, in contrast with the control metaproteome that was
enriched in proteins from Bifidobacterium adolescentis, B. longum subsp. infantis, Ruminococ-
cus, Collinsella aerofaciens, Coprococcus comes, and Clostridium sp. [18]. However, the qPCR
evaluation of Bacteroides sp. and Bifidobacterium sp. were similar between case and control
children, suggesting that the intestinal environment was not affecting the bacterial popula-
tion, instead modulating its proteome [18]. Altogether, it is important to stress that the gut
microbiota in children, either at risk of T1D or with established T1D, shows a dysbiosis,
and the genus Bacteroides may have some role in the development of the disease.
This study aimed to characterize Bacteroides species from fecal samples of T1D children
and control children from Portugal (Algarve region), and analyze their characteristics
regarding antibiotic susceptibility, mucinolytic activity, its potential to disturb intestinal
epithelial cells, and also analyze their genomic characteristics that may be linked with the
development of T1D.
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2. Materials and Methods
2.1. Fecal Samples
Seventeen fecal samples from T1D children, aged 9.53 ± 1.88 were obtained (eight
female and seven male). The control group included 15 healthy T1D siblings and children
with no T1D history in the immediate family, aged 8.20 ± 3.00. All children followed a
regular diet (>50% of meat, eggs, vegetables, fruit and milk of regular origin). For the
majority of children, sports were practiced twice a week or three times a week, only four
T1D children reported not to practice any sports. T1D children were medicated exclusively
with insulin. The haemoglobin level (HbA1c) in diabetic children was 8.76 ± 1.50. Samples
from each child were collected, immediately transported to the laboratory in cold storage
conditions, and directly surveyed. Antibiotic treatment, diagnosis of infectious diseases,
and hospitalization up to 3 months before the start of the study were exclusion criteria.
The current study was approved by the Ethics Committee of the Centro Hospitalar
Universitario do Algarve, and informed consent was obtained from the parents of the
children enrolled in the study.
2.2. Bacteria and Culture Conditions
To isolate Bacteroides species from fecal samples, the culture medium bacteroides vul-
gatus selective agar (BVSA) was used [24]. About 0.2–0.3 g of stool specimen was collected
to a sterile 2 mL eppendorf, and the feces were resuspended in 1 mL of Phosphate Buffered
Saline (PBS). After homogenization, each sample was centrifuged at low speed, 700× g for
5 min. Next, 500 µL of the supernatant was collected to a new eppendorf and serial dilu-
tions were prepared. A volume of 100 µL of the dilutions 10−3 and 10−4 were inoculated
in BVSA, and the incubation was achieved using an anaerobic jar with an anaerobic sachet
(AnaeroGen, Oxoid, Basingstock, UK) at 37 ◦C for 3–4 days. Afterwards, characteristic
colonies (black, shiny colonies with a dark halo zone) were counted, and representative
colonies of each morphological group were transferred to brain–heart infusion (VWR)
supplemented with hemin (0.1%, v/v) and L-cysteine (0.1%, w/v, Sigma-Aldrich, St. Louis,
MO, USA) (BHI + H) to obtain pure cultures. The incubation was conducted at 37 ◦C
for 48 h. Pure cultures were maintained in BHI supplemented with 25% (v/v) glycerol
at −80 ◦C.
2.3. DNA Extraction
The extraction of DNA from stool samples was performed using the kit QIAmp DNA
Stool Mini Kit (QIAGEN, Hilden, Germany) according to the manufacturer’s instructions.
The stool quantity used for DNA extraction was 220 mg. The extracted DNA was eluted in
200 µL of AE buffer and maintained at −20 ◦C until use.
The DNA from bacterial cultures was extracted using the Wizard Genomic DNA
Purification Kit (PROMEGA) or the GES method [25].
2.4. Identification of Bacteroides Species by 16S rRNA Gene Sequencing
Molecular identification of Bacteroides species was performed by sequencing the 16S
rRNA gene using the primers pair 27F and 1492R [26]. The Bacteroides isolates were cultured
in BHI + H for 48 h at 37 ◦C under anaerobic conditions. Genomic DNA was extracted as
described above. The polymerase chain reactions (PCR) amplifications were carried out
with the DFS-Taq DNA Polymerase (Bioron GmbH, Römerberg, Germany). Purified PCR
products were sequenced with the 1492R primer [27] at the Molecular Biology laboratory
of the Centro de Ciências do Mar (CCMar) using standard Sanger sequencing procedures.
The 16S rRNA gene sequences were analyzed, and those ≥1200 bp were selected for
further analysis. The editing of the sequences was conducted using Bioedit (version 7.2.5).
The identification of the closest matches to sequence queries was performed using the
Blast algorithm of the National Center for Biotechnology Information (NCBI) [27]. The
Ribosomal Database Project [28] was also used for the determination of the isolates at the
species/strain level.
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2.5. Characterization of Bacteroides Species by Repetitive Sequence-Based PCR
The Bacteroides isolates were analyzed by rep-PCR with BOX A1R primer and ERIC1R
and ERIC2 primers [29,30]. The PCR reactions were performed with Platinum Taq poly-
merase (Invitrogen, Eugene, OR, USA).
The PCR amplicons (25 µL) were separated by gel electrophoresis on 1.5% Agarose
(Lonza, Risingevej, Denmark) gel in TAE 1× buffer at 100 V during 6 h. The 100 and 500 bp
markers (Invitrogen) were used. Gels were stained with ethidium bromide for 30 min and
visualized under UV light using the DC 290 Kodac camera.
Analysis of the gel banding patterns was performed using GelCompare II (Biomérieux,
Lisbon, Portugal) and dendograms were generated using Pearson correlation similarity
coefficient with optimization of 1%, and the cluster analysis was performed using the
unweighted pair group method using arithmetic averages (UPGMA) clustering method.
2.6. qPCR
The quantification of specific bacterial groups (Firmicutes, Bacteroidetes, Bacteroides,
P. dorei, Bifidobacterium sp., Clostridium cluster IV, Enterococcus sp., Lactobacillus sp. Proteobac-
teria and Prevotella sp.) was determined by quantitative real-time PCR (qPCR). The specific
primers used are indicated in Table S1. Reactions were performed using SsoFastTM kit
Eva Green Supermix (BioRad, Hercules, CA, USA), 0.5 µM of forward and reverse primer
and 100 ng of DNA on a CFX96 qPCR thermal cycler (Bio-Rad Laboratories, Hercules, CA,
USA). All PCR reactions were carried out in duplicate, and the PCR conditions are shown
in Table S2. Reactions containing all the components except template DNA were included
as negative controls. The denaturation step occurred at 95 ◦C, for 10 min. The number of
cycles was identical for all target groups (45 cycles). The melting curve was performed by
increasing the temperature 0.5 ◦C each 2 s from 72 ◦C to 95 ◦C.
Standard curves were generated using plasmid DNA (pCR ™ 2.1-TOPO) with inserted
16SrRNA gene of each bacterium. The cloning process was achieved using competent
Escherichia coli MACH1 (Invitrogen) following the instructions of the vector manufacturer
(Invitrogen). Four replicates of the plasmid DNA dilutions in order to obtain the number
of copies that ranged from 1010–10 were prepared. Data are expressed as Log10 DNA
copies/g feces.
2.7. Antibiotic Susceptibility
The determination of antibiotic susceptibility was achieved as previously described [31,32].
Briefly, Bacteroides strains were grown on BHI + H and incubated in an Anaerobic jar
(AnaeroGen, Oxoid) at 37 ◦C for 24 h. Bacterial suspensions were prepared in 0.9%
saline to a density of McFarland 1. The disc diffusion assays were performed using
Brucella blood agar plates supplemented with hemin (0.1%) and vitamin K1 (1%). The
antibiotic discs (Oxoid) were amoxycillin–clavulanate (20/10 µg) (AMC), clindamycin
(10 µg) (DA), imipinem (10 µg) (IMP), moxifloxacin (5 µg) (MXF), piperacillin-tazobactam
(30/6 µg) (TZP) and metronidazole (5 µg) (MTZ). The plates were incubated in anaero-
bic conditions at 37 ◦C for 24 h. Six discs (three per plate) were used. The susceptibil-
ity zone diameter provisional breakpoints previously suggested [31,32] were followed:
amoxycillin–clavulanate (≥15 mm), clindamycin (≥25 mm), imipenem (≥29 mm), moxi-
floxacin (≥19 mm), piperacillin-tazobactam (≥25 mm) and metronidazole (≥24 mm). Next,
the results for Imipinem and Metronidazole were confirmed by Epsilon test according
to manufacturer’s procedure (Biomérieux, Portugal). The breakpoints were established
according to EUCAST [33].
2.8. Mucinolytic Activity
The ability of several strains of P. dorei isolated from T1D and control children to use
mucin as sole carbon source was evaluated by growing the bacterial strains in a defined
medium [24] supplemented with 1% porcine gastric mucin (PGM) (Sigma, Madrid, Spain)
previously dialyzed with SnakeSkin® Dialysis Tubing membrane (cut off: 10 kDa) at
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4 ◦C. As control the bacterial growth was performed in the mentioned defined medium
supplemented with glucose as sole carbon source (0.5%, w/v) and in BHI + H medium. The
growth was followed by changes in optical densities (OD600 nm) in microplates. For this
180 µL of medium were distributed in each well, and each well was inoculated with 20 µL
of the bacterial culture previously grown in the tested medium for 24–48 h in anaerobic
conditions. Wells with non-inoculated medium were used as blanks. To assure anaerobic
conditions, 30 µL of sterile paraffin oil were added into each well, and the incubation was
performed in an anaerobe jar (BioMérieux) with an anaerobic sachet (Oxoid) at 37 ◦ C for
48 h. The optical readings were performed on a microplate reader (Tecan Infinite M200).
Four biological replicates were used. The reference strain of P. dorei DSM 17855 and the
strain of P. vulgatus PtF D2P1 were included.
The mucinolytic activity was evaluated as described by Yesilkaya et al. [34]. The
bacterial strains were grown in Defined medium with 1% (w/v) mucin and 1% agar (DMa).
As control, non-inoculated DMa plates were used. The inoculated culture plates were
incubated in anaerobic jars during 48 h at 37 ◦C. Next, the culture plates were stained with
0.1% (w/v) black amid in acetic acid 3.5 M for 30 min and were decolorized with acetic
acid 1.2 M. Escherichia coli D3 (isolated from a T1D child) and E. coli C1 (isolated from a
healthy child) were included as controls. Mucinolytic activity zones were observed around
the bacterial growth.
2.9. Whole Genome Sequencing
Genomic DNA of strains P. dorei PtFD1P5, PtFD8M1, PtFD16P1, PtFD16M14, PtFSb6,
PtFSb8, PtFC1P2, B. uniformis PtFD3Pch2, PtFSb3P5 and P. distasonis PtFD14MH1 for whole
genome sequencing was isolated from 2 mL of the bacterial culture prepared as described
above. The DNA was extracted using Wizard Genomic DNA Purification Kit (Promega,
Madison, WI, USA), according to the manufacturer’s protocol with a modification that
included an additional step of lysis with sterile acid-washed glass beads (425–600 µm)
(Sigma Life Science, Saint Louis, MO, USA) comprising 1/3 of the volume of the bacterial
pellet. The mixture was sonicated for 1 min using the bead beater (Next Advance, Troy,
NY, USA).
DNA integrity was analyzed by electrophoresis using a 0.75% (w/v) agarose gel
(Lonza, Copenhagen, Denmark). DNA quantification was performed by using the
fluorescence-based Qubit dsDNA BR Assay Kit (Invitrogen, Eugene, OR, USA). Each
bacterial genomic DNA was dissolved in 10 mM Tris-HCl buffer at concentrations ranging
from 2.7 to 5.0 µg/µL for Standard Whole Genome Service by Illumina next-generation
sequencing provided by MicrobesNG (http://www.microbesng.uk, accessed on 2 October
2018) which is supported by the BBSRC (grant number BB/L024209/1). At Microbes NG
Genomic DNA libraries were prepared using the Nextera XT Library Prep Kit (Illumina,
San Diego, CA, USA) following the manufacturer’s protocol with minor modifications,
namely input DNA was increased 2-fold, and PCR elongation time increased to 45 s. DNA
quantification and library preparation were performed on a Hamilton Microlab STAR
automated liquid handling system (Hamilton Bonaduz AG, Bonaduz, Switzerland). Pooled
libraries were quantified using the Kapa Biosystems Library Quantification Kit for Illu-
mina. Libraries were sequenced using Illumina sequencers (HiSeq) using a 250 bp paired
end protocol.
Reads were adapter trimmed using Trimmomatic 0.30 with a sliding window quality
cutoff of Q15 [35]. De novo assembly was performed using SPAdes version 3.7 [36], and
contigs were annotated using Prokka 1.11 [37]. The scaffolding of the contigs was achieved
using scaffold builder [38].
The circular genome maps were generated using CGView server Beta (version 1.7) [39].
The tracks GC Skrew, GC Content and Prokka Annotation were added [37]. In Prokka
Annotation the default parameters for bacterial genome were used.
Whole genome sequence reads were deposited in the NCBI SRA under BioProject ID
PRJNA687382. The GenBank assembly accessions are GCA_018588045.1, GCA_018588075.1,
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GCA_018588055.1, GCA_018588025.1, GCA_018588125.1, GCA_018588105.1, GCA_018588135.1,
GCA_018704025.1, GCA_018704075 and GCA_018587995.1
2.10. Typing
The typing of the whole genome sequenced strains P. dorei PtFD1P5, PtFD8M1,
PtFD16P1, PtFD16M14, PtFSb6, PtFSb8, PtFC1P2, B. uniformis PtFD3Pch2, PtFSb3P5 and
P. distasonis PtFD14MH1 was performed by using the multilocus sequencing typing (MLST)
using 30 genes listed in Table S3 following the recommendations of Chun et al. and
Munoz et al. [40,41]. The selected genes are involved in the housekeeping apparatus and
the central metabolic pathways of the bacterial cell. The sequence alignment was per-
formed using Clustal Omega [42], and the phylogenetic analysis and tree construction
(using concatenated aligned sequences), was conducted with the software MEGA X [43]. As
reference, the sequences of the listed genes of the strains P. dorei DSM 17855, CL03T12C01,
CL02T12C06, CL02T00C15; HS1 L3 B 079, HS2 L2 B045b, HS1 L1B010, B. uniformis ATCC
8492 and P. distasonis ATCC 8503 were used.
2.11. Prophage and CRISPR-Cas Systems Detection
The P. dorei, B. uniformis and P. distasonis genomes were analyzed with PHASTER
(PHAge Search Tool Enhanced Release) (http://phaster.ca/, accessed on 4 June 2021) [44]
to search for potential prophage sequences. CRISPRs (clustered Regularly Interspaced
Short Palindromic Repeats) and Cas (CRISPR-associated) proteins were searched using the
CRISPRCasFinder [45].
2.12. Identification of Resistance, Pathogenicity Potential and Molecular Mimicry
In order to identify acquired antimicrobial resistance genes, the software CARD/RGI
was used [46]. The identification of the potential pathogenicity to human host was con-
ducted using the software PathogenFinder 1.1 [47]. The molecular mimicry identification
was conducted using BLASTP (version 2.2.26) through SEED Viewer (version 2.0) by search-
ing the presence of the insulin B chain insB:9–23 peptide mimics (SHLVEALYLVCGERG)
described in P. distasonis 33B, which was found in the Human Gut Microbiome [48], and
the two microbial altered peptides ligands (MVWGPDPLYV and RQFGPDWIVA) of the
natural preproinsulin (ALWGPDPAAA) reported in Bacteroides fragilis/thetaiotaomicron and
Clostridium asparagiforme, respectively [49].
2.13. Cell Culture Assays
The human colonic cell line HT29-MTX-E12 (ECACC 12040401) (Sigma-Aldrich, Euro-
pean Collection of Authenticated Cell Cultures, Porton Down, Salisbury, UK) was routinely
cultured in Dulbecco’s Modified Eagle Medium (DMEM, Sigma-Aldrich, St. Louis, MO,
USA) supplemented with 10% (v/v) fetal bovine serum (FBS), 1% (v/v) non-essential amino
acids, and antibiotics (Penicillin/Streptomycin (PEN-STREP), 5000 units/mL Penicillin
and 5000 µg/mL Streptomycin) (Gibco, Carlsbad, CA, USA) (DMEM complete). Cultures
were incubated at 37 ◦C in a humidified 5% (v/v) CO2 atmosphere and grown until 80–90%
confluence before being sub-cultured and used between passages 52 to 60.
For adhesion, invasion, and evaluation of the damage to the tight junctions assays, the
cell tissue culture was performed for 21 days post seeding to reach mature HT29-MTX-E12
cells. Cells were seeded in 24-well culture plates at concentration of 4.0 × 104 cells per well.
The culture medium was changed every two days for the 21 days of the differentiation
period. In the last medium change no antibiotics were added to the medium.
2.13.1. Adherence Assay
The evaluation of the adhesion ability of strains of P. dorei, B. uniformis and P. distasonis to
HT29-MTX-E12 intestinal cells was performed as previously described by Gagnon et al. [50]
with some modifications. The bacterial cultures were grown in BHI + H in anaerobic
conditions during 24 h at 37 ◦C. The previous bacterial culture was used to inoculate at
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107 CFU/mL the HT29-MTX-E12 cells prepared as previously described. The tissue culture
plates were then incubated at 37 ◦C under anaerobic conditions for 30 min. After this
time interval the non-adherent bacteria were eliminated by washing with (PBS) (twice).
Subsequently, the cell line with adherent bacteria was treated with 250 µL Trypsin-EDTA
(Sigma-Aldrich, St. Louis, USA per well and incubated at 37 ◦C for 10 min. To inactivate
the Trypsin-EDTA, DMEM supplemented with 10% (v/v) of FBS was added to each well.
From this suspension, serial decimal dilutions were performed in PBS, and then each
dilution was inoculated on BHI + H agar plates. The inoculated plates were incubated
under anaerobic conditions at 37 ◦C for 48 h.
The adhesion results are expressed as the percentage of the number of adherent
bacterial cells relative to the total number of bacteria used on the assay.
2.13.2. Invasion Assay
The evaluation of the invasion ability of strains of P. dorei, B. uniformis and P. distasonis to
HT29-MTX-E12 intestinal cells was performed as previously described by Gagnon et al. [50]
with some modifications. Briefly, the bacterial cultures were grown in BHI + H in anaerobic
conditions for 24 h at 37 ◦C. The bacteria were then inoculated at 107 CFU/mL into the
plates with the HT29-MTX-E12 cells prepared as previously described. The tissue cell
plates were then incubated at 37 ◦C under anaerobic conditions for 4 h. The infected cell
lines were washed with PBS (twice) and exposed to 250 µL DMEM medium containing
150 µg/mL of Gentamicin (Sigma-Aldrich, Germany) per well for 1 h at 37 ◦C to eliminate
any non-invasive bacteria. A new washing step was carried out with PBS, and 250 µL
Trypsin-EDTA was added to each well with further incubation at 37 ◦C for 10 min. The
cell lines were then exposed to 0.1% (v/v) Triton X-100 (Merck, Darmstadt, Germany) for
10 min at 37 ◦C to permeabilize the cells allowing the release of invasive bacteria. From
this suspension, serial decimal dilutions were prepared, and the bacterial counts were
performed as described above.
The results of the invasion ability are expressed as the percentage of the number of
invasive bacteria relative to the total bacteria used in the assay.
2.13.3. Ability of Bacteroides Species to Impair Epithelial Integrity
The capacity of P. dorei, B. uniformis and P. distasonis strains to cause alterations to the
epithelial integrity of the cell line HT29-MTX-E12 was evaluated as previously described
in [50] with slight modifications. The cells were seeded in wells containing a sterile
coverslip, Ø 13 and 1.5 mm thickness (VWR, Radnor, Philadelphia, PA, USA). Bacterial
suspensions at a concentration of 107 CFU/mL were transferred to the epithelial intestinal
cells after the differentiation period of 21 days. The cell line was exposed to the bacterial
cells during 4 h at 37 ◦C under anaerobic conditions. The infected cells were then washed
with PBS 3 times and fixed with 3.7% (v/v) formaldehyde (Labscan Analytical Sciences,
Gliwice, Poland) for 15 min. Three new washing steps with PBS were performed. The cell
line was then permeabilized with 0.5% Triton X-100 (Merk, Darmstadt, Germany) for 10 min,
followed by 3 washing steps with PBS. The cells were then blocked for non-specific binding
with 3% (w/v) bovine serum albumin (Merk, Germany) at 4 ◦C for 1 h. Thereafter the cells
were incubated during 20 min with tetramethylrhodamine B isothiocyanate-phalloidin
(TRITC-phalloidin) (Sigma-Aldrich, Hamburg, Germany) (diluted 1:200 from an initial
solution of 0.1 mg/mL). Afterwards the cell line was exposed for 3 min to 4′,6′-diamidine-
2-phenylindole (DAPI) (Sigma-Aldrich, Germany) (diluted 1:200 of an initial solution of
14.3 mM). Two final washes were carried out with PBS. The assays were performed using
three biological and two technical replicates.
Each coverslip was then mounted inverted on a microscope slide with a drop of
Fluromount (Sigma-Aldrich, Germany). The observation of the cell lines was performed
using the microscope Axio Imager Z2 (Zeiss, Oberkochen, Germany).
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2.13.4. Exposure of Intestinal Epithelial Cells to the Bacteroides Metabolome (Secretome)
The evaluation of the effect of the Bacteroides metabolome on the viability of the cell
line HT29-MTX-E12 was performed using the Vibrant MTT cell proliferation assay kit
(Molecular Probes, Invitrogen, Eugene, OR, USA) following the manufacturer instructions.
Briefly, the bacterial cells were grown in BHI + H at 37 ◦C for 24 h under anaerobic condi-
tions. Thereafter the bacterial suspensions were centrifuged (5000× g, 10 min, 4 ◦C) and the
supernatant was collected and filtered (0.2 µm pore diameter, Whatman, GE Healthcare,
Buckinghamshire, UK). The supernatant samples were stored at −20 ◦C until use.
HT29-MTX-E12 cells required were seeded in a 96-well microplate (8000 cells per well)
and incubated for 48 h at 37 ◦C in a 5% (v/v) CO2 humidified atmosphere. Afterwards
DMEM complete was discarded and replaced with DMEM complete supplemented with
the bacterial supernatant at different percentages (10, 25 and 50% [v/v]). Three biological
and 4 technical replicates were used. The pH value of the different combinations was
7.8 ± 0.11 for the 10% (v/v) mix, 7.53 ± 0.12 for 25% (v/v) and for 50% (v/v) the pH was
7.21 ± 0.26. The cell line was exposed to the bacterial supernatant for 24 h. After this time
interval, the DMEM medium with the supernatant was replaced with DMEM complete,
and the MTT solution was added to each well. The cell line was then incubated at 37 ◦C
in a 5% (v/v) CO2 humidified atmosphere for 4 h. Thereafter an SDS-HCl solution was
gently added into each well followed by an incubation for 4 h at 37 ◦C in a 5% (v/v) CO2
humidified atmosphere. Finally, each well was homogenized to eliminate any precipitate
and the absorbance value was determined at 570 nm using a microplate reader (Tecan
Infinite, M200, Männedorf, Switzerland).
2.13.5. Invasion Ability of Bacteroides Species in the Presence of Lactobacillus casei
The ability of strains of P. dorei, B. uniformis and P. distasonis in the presence of Lac-
tobacillus casei DSM 20011 to invade HT29-MTX-E12 intestinal cells was performed as
described above. The L. casei DSM 20011 was grown on Man, Rogosa and Sharpe (MRS)
medium under microaerophilic conditions for 24 h at 37 ◦C. Bacteroides and L. casei were
inoculated at 107 CFU/mL to the intestinal epithelial cells. The incubation conditions
and recovery of bacterial cells that were able to invade were performed as described in
Section 2.13.2, except that L. casei cells counts were conducted using the MRS medium
under microaerophilic conditions, whereas Bacteroides spp. were performed in BHI + H sup-
plemented with vancomycin (15 µg/mL) and kanamycin (200 µg/mL) and the incubation
was conducted in anaerobic conditions.
The results are expressed as the percentage of the number of invasive bacteria relative
to the total bacteria used in the assay.
2.14. Statistical Analysis
Data was analyzed for statistical significance by one or two-way ANOVA with the
software SPSS (version 25) (Inc., Chicago, IL, USA). Statistical significance was considered
at p < 0.05; when the analysis was statistically significant, the Tukey’s post hoc test was
performed. Violin plots on bacterial abundances with qPCR results were performed using
GraphPad Prism (version 9.0) (GraphPad Software, San Diego, CA, USA).
3. Results
3.1. Counts and Diversity of Bacteroides Species
The number of Bacteroides species recovered from culture achieved similar values
(p > 0.05) between T1D and control samples; 6.64 ± 0.74 Log10 CFU/g feces for T1D
children and 6.40 ± 0.06 Log10 CFU/g feces for control children.
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The different Bacteroides species isolated from the fecal samples of the two groups are
illustrated in Figure 1. Several Bacteroides species were only isolated from T1D samples,
namely the species B. graminisolvens, B. cellulosilyticus, B. finegoldii, B. stercoris, B. eggerthii
and B. fragilis that achieved 3.45% each and none from controls. The recovery of P. dorei in
culture was attained from only three T1D samples reaching 10.34%, whereas in controls P.
dorei was recovered from four samples achieving 18.18%. In T1D samples several Bacteroides
species were recovered at similar percentages to P. dorei, such as B. uniformis and P. vulgatus
(10.34%). The percentage of recovery of B. ovatus and B. xylanisolvens was similar for both
groups (13.79%).
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Overall, the core of Bacteroides species recovered from the two groups, besides P. dorei,
includes the species B. ovatus, P. vulgatus, B. uniformis and B. xylanisolvens. Interestingly the
recovery of P. distasonis was higher from T1D samples (10.34%) in comparison with control
samples (4.55%).
The load of the targeted bacterial groups in the fecal samples of T1D and control
children determined by qPCR is illustrated in Figure 2. Similar amounts (p > 0.05, and
values presented as Log10 copy number/g feces) for both groups were found for Firmicutes
(control 9.63 ± 1.09, T1D 9.39 ± 0.93), Bacteroidetes (control 8.35 ± 0.40, T1D 8.31 ± 0.51),
Bacteroides sp. (control 7.10 ± 0.32, T1D 6.97 ± 0.52), P. dorei (control 3.97 ± 1.52, T1D
4.21 ± 1.43), Bifidobacterium sp. (control 7.30 ± 0.60, T1D 7.22 ± 0.51), Clostridium cluster
IV (control 6.80 ± 0.55, T1D 6.70 ± 0.68), and Enterococcus sp. (control 4.14 ± 0.43, T1D 4.15
± 0.38). However, T1D children carried lower numbers of Lactobacillus sp. (p < 0.05) in
comparison with control children, but a higher abundance (p < 0.05) of Prevotella sp. and
Proteobacteria was observed in their fecal samples.
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3.2. Antibiotic Suscep i ili y
Bacteroides species are the most implicated anaerobic bacteria in infections, and re-
sistance to ant biotics varies among the differe t sp cies and also across geographic re-
gions [31,51]. To evaluate the antibiotic susceptib lity, a set of Bacteroides isolates wa
selected and their suscep ibility was determined by disc diffusion in luding the antibiotics
amoxycillin–clavulanate, clindamycin, imipenem, moxifloxacin, piperacillin-tazobactam,
and metronid zole. The tested antibiotics are used in the treatment of infections caused by
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anaerobic bacteria [31–33,51]. The results of the antibiotic susceptibility are summarized
in Table S4. Regarding the susceptibility of P. dorei strains for the antibiotic amoxycillin–
clavulanate, two resistant strains in T1D group were observed and in the control group
three resistant strains were detected. More than half of the P. dorei strains were resistant
to clindamycin (58%), and even in the control group three strains were resistant to this
antibiotic. For imipenem about 92% of the P. dorei strains were resistant, including the
strains from the control group where just 1 strain was susceptible to IMP. In contrast 83% of
the P. dorei strains were susceptible to moxifloxacin, and it was on the control group that it
was found two resistant strains. For piperacillin–tazobactam more than half of the strains
were resistant (58%) and they were observed in both groups. The strains of B. uniformis
and the isolate of P. distasonis were susceptible to amoxycillin–clavulanate, and just two
strains were susceptible to clindamycin. For imipinem only two strains of B. uniformis
were susceptible. In contrast just one strain of B. uniformis was resistant to moxifloxacin
belonging to the control group. The resistance to piperacillin–tazobactam was detected in
one strain of B. uniformis isolated from control children (B. uniformis PtFC3M3). All the
strains of P. dorei, B. uniformis and P. distasonis were susceptible to metronidazole (Table S4).
The epsilon test for the antibiotic imipinem evidenced that all tested P. dorei strains
were susceptible to this antibiotic, in contrast with the disc diffusion assay for which only
one P. dorei strain was susceptible (Table S5). The strain of B. uniformis PtF Sb3P5 and
P. distasonis PtFD14MH1 that according to the disc diffusion test were resistant, using the
epsilon these strains are susceptible. The epsilon test for MTZ (0.016–256 µg/mL) evidenced
MIC values between 0.0195–0.250 µg/mL (breakpoint S ≤ 4 R ≥ 4 mg/L) confirming the
disc diffusion results; all tested strains of P. dorei, B. uniformis, and P. distasonis PtFD14MH1
were susceptible to this antibiotic.
The results of the in silico analysis of the genome of the strains P. dorei PtF D1P5, PtF
D8M1, PtF D16P1, PtF D16M14, PtF Sb6, PtF Sb8, PtFC1P2, B. uniformis PtF D3Pch2, PtF
Sb3P5 and P. distasonis PtF D14MH1 for the identification of resistance genes using the
CARD/RGI are summarized in Table S6. The adeF gene that belongs to the antimicrobial
resistance (AMR) gene family of resistance-nodulation cell division (RND) antibiotic efflux,
and confers resistance to fluoroquinolone and tetracycline antibiotics, was detected on all
strains, and in some strains more than one copy was present. Interestingly, the strains P.
dorei PtF D16P1 and PtF D16M14 only carry this resistance gene.
The mef (En2) gene that belongs to the AMR gene familiy of major facilitator super-
family (MFS) antibiotic efflux pump that confers resistance to macrolide antibiotic was
detected in four strains of P. dorei; PtF D1P5, PtF D8M1, PtF Sb6 and PtF Sb8. The tetQ gene
that belongs to the AMR gene family tetracycline-resistant ribosomal protection protein
was identified in six strains; five strains of P. dorei (PtF D1P5, PtF D8M1,PtF Sb6 PtF Sb8,
PtF C1P2) and in the B. uniformis strain PtF D3Pch2. The gene ErmF that belongs to the Erm
23S ribosomal RNA methyltransferase family was detected in two strains of P. dorei, PtF
D8M1 and PtF Sb8 and in the B. uniformis strain PtF Sb3P5. P. distasonis PtF D14MH1 carries
a gene that encodes a beta-lactamase of the CfxA family, CfxA2 that has been found in Pre-
votella intermedia [52]. The strain of B. uniformis PtF Sb3P5 carries two beta-lactamase genes,
namely OXA-347and CblA-1 that is found in B. uniformis and is species specific [53,54].
Single nucleotide polymorphisms (SNPs) were not detected.
3.3. Mucinolytic Activity
In defined medium with glucose as sole carbon source, all P. dorei strains and the strain
of P. vulgatus PtFD2P1 reached a four fold growth in this medium. In contrast, the fold
change in the defined medium with PGM was only one fold for all tested strains (Figure S1).
The growth in the rich medium BHI attained a two fold increase, and the strain of P. dorei
PtF D1P5 was the one that reached slighty higher than two fold in BHI (Figure S1).
Mucin degradation was revealed by the amidoblack staining of solidified defined
medium with PGM where the cultures of the the strains of P. dorei and P. vulgatus caused
the appearance of clear zones demonstrating mucinolytic activity. The cultures of E. coli
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strain D3 and C1 showed no mucin degradation zones around their growth evidencing
their inability to degrade mucin (data not shown).
3.4. Repetitive Based Sequence PCR
The PCR patterns generated either with BOX primer (BOX-PCR) or the ERIC primers
(ERIC-PCR) distinguished the different Bacteroides species, P. dorei, P. vulgatus and P. dis-
tasonis isolates (Figure S2). The cluster analysis of BOX-PCR fingerprints grouped the P.
dorei isolates in three groups; the reference strain P. dorei DSM 17855 grouped with P. dorei
PtFSb8 (80.8% similarity) and the second cluster included the main isolates (PtFD16P1,
PtFD16M14, PtFSb19Pp7, PtFSb6, PtFD1P5, PtFD1P20, PtFD1P21 and PtFD8M1). Two P.
dorei isolates (PtFC1P2 and PtFC1M8) grouped with P. vulgatus (73.4% similarity).
The cluster analysis based on the BOX-PCR for B. uniformis identified two main
clusters; the first included the isolates B. uniformis PtFD3P28, PtFSb3P5 and Sb13P5 (97.3
and 96.6%) and the second included the isolate B. uniformis PtFD6P31with 87.6% similarity
between them. The isolate B. uniformis PtFC7NB15 showed low relatedness with the two
main clusters (33.1%). Two other isolates of B. uniformis (PtFC3M3 and PtFC6Pp6) clustered
with B. thetaiotaomicron with 66.9% similarity. Interestingly, the isolate B. uniformis D3Pch2
showed a singular singleton clustering with B. ovatus (59.1%) (Figure S2A).
Analysis of banding patterns produced using the BOX rep-PCR for B. xylanisolvens
formed two main clusters, one includes the isolates from a unique T1D child, PtFD6Phid,
PtFD6M1, PtFD6M10, PtFD6P1, PtFD6P5 achieving 99% similarity, indicating that they
can constitute a single strain. This grouping for these B. xylanisolvens isolates was also
observed using the ERIC rep-PCR (Figure S3). The second cluster of B. xylanisolvens
includes the isolates PtFD4M1, PtFD13MH1, PtFD3P4, PtFD3M6, PtFD3P6, PtFSb3P12,
PtFSb3M1 showing high similarity (73.3%). Other B. xylanisolvens isolates clustered with
other Bacteroides species, namely the isolate B. xylanisolvens PtFD4P14 clustered with two
isolates of B. ovatus with 93.2% relatedness, B. xylanisolvens PtFSb9MH2 clustered with
the isolate of B. fragilis PtFD13MH3 with 98.1% similarity and the isolate B. xylanisolvens
PtFSb2Phid clustered with P. vulgatus PtF D17P19 showing 78.1% similarity.
The BOX rep-PCR banding pattern analysis for B. thetaiotaomicron grouped the isolates
PtF C6P14, PtFC6P14Smo achieving 97.9% similarity and the isolate PtFD4P1 was related
with this cluster with 88% similarity. Two other B. thetaiotaomicron isolates PtFD4M3 and
PtFD4 M11 (92.2%) were related with the other isolates at 85.1% similarity. The isolate B.
thetaiotaomicron PtFD2P14 was a singleton showing 61.0% similarity with the other isolates.
Two other B. thetaiotaomicron singletons were identified, the isolate PtFD4P11 and the isolate
PtFC2Phid (Figure S2A).
The cluster analysis of ERIC-PCR fingerprints, as stated above, discriminated the
Bacteroides isolates by species (Figure S2B). The P. dorei isolates were grouped differently
from the BOX-PCR producing three groups (Figure S2B). The first group includes the
isolates P. dorei PtFC1M8, PtFD1P20, PtFD1P20, PtFSb8, the second includes the isolates
PtFD16P1 and PtFD16M14, and the third group includes the isolates PtFD1P5 and PtFSb6.
The P. dorei PtFC1P2 forms a singleton with a very low number of bands produced by ERIC
primers, evidencing 71.9% similarity with B. stercoris and B. finegoldii (Figure S2B). A very
lower number of bands produced by ERIC-PCR primers is observed in two B. uniformis
isolates; PtFC3M3 and PtFC7NB15. Singletons in ERIC-PCR cluster analysis were identified
in several Bacteroides species, namely B. thetaiotaomicron PtFD2P14, B. uniformis PtFD3Pch2
and PtFC6Pp6, B. xylanisolvens PtFD4P14 and PtFD4M1, B. ovatus PtFC4P5 and PtFC5M11
(Figure S2B).
3.5. Interaction with Intestinal Epithelial Cells
The interaction of P. dorei strains with intestinal epithelial cells was evaluated using
the cell line HT-29-MTX-E12. The ability of P. dorei, B. uniformis and P. distasonis to adhere
and invade the HT-29-MTX cells is illustrated in Figure 3. All tested strains of P. dorei, B.
uniformis and the strain of P. distasonis PtFD14MH1 were equally (p > 0.05) able to adhere
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to HT-29-MTX cells, except the P. dorei strain PtFD16P1 and PtF Sb8 that showed a lower
adherence (p < 0.05) (Figure 3A). The highest ability to invade was displayed by the strain
of P. distasonis PtFD14MH1 (p < 0.05). The invasion ability of P. dorei PtF D16P1 and PtF Sb8
was higher (p < 0.05) in comparison with the other P. dorei strains. The B. uniformis strains
PtF D3Pch2 and PtF Sb3P5 were not able to invade HT-29-MTX cells (Figure 3B).
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3.5.1. The Viability of T29- TX-E12 ells Exposed to the Secreto e of
Bacteroides Species
In order to evaluate the potential impact of the secretome produced by the Bacteroides
species on the viability of intestinal epithelial cells, HT-29-MTX-E12 cells were exposed for
24 h to the culture medium supplemented with different percentages (10%, 25% and 50%)
of the secretome of Bacteroides cultures. The results are illustrated in Figure 5.
The increase of the secretome concentrations of the reference strain P. dorei DSM 17855,
P. dorei PtFD1P5, P. dorei PtFD8M1, and P. dorei PtFC1P2 did not significantly impaired
(p > 0.05) the viability of HT-29-MTX-E12 cells. In contrast, the exposure of HT-29-MTX-E12
cells to increasing concentrations of the bacterial culture secretome of the strains P. dorei
PtFD16M14, P. dorei PtFD16P1, P. dorei PtFSb6, P. dorei PtFSb8, B. uniformis PtF D3Pch2, B.
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uniformis PtF Sb5P5, and P. distasonis PtFD14MH1 significantly affected the viability of the
intestinal epithelial cells (p < 0.05) (Figure 5).
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The increase of the secretome concentrations of the reference strain P. dorei DSM 
17855, P. dorei PtFD1P5, P. dorei PtFD8M1, and P. dorei PtFC1P2 did not significantly im-
paired (p > 0.05) the viability of HT-29-MTX-E12 cells. In contrast, the exposure of HT-29-
MTX-E12 cells to increasing concentrations of the bacterial culture secretome of the strains 
P. dorei PtFD16M14, P. dorei PtFD16P1, P. dorei PtFSb6, P. dorei PtFSb8, B. uniformis PtF 
D3Pch2, B. uniformis PtF Sb5P5, and P. distasonis PtFD14MH1 significantly affected the 
viability of the intestinal epithelial cells (p < 0.05) (Figure 5). 
3.5.2. Integrity of HT29-MTX-E12 Cells after Exposure to Bacteroides Species 
The different strains of P. dorei were able to adhere and invade the HT-29-MTX-E12 
cells, except the two tested strains of B. uniformis that were not able to invade. Therefore, 
the impact of colonization by different bacterial species on tight junction integrity was 
investigated. The HT-29-MTX-E12 cells were stained with TRICT-phalloidin, a phallo-
toxin that binds to actin filaments. This binding allows the observation of any damage that 
has occurred in the network of tight junctions as a result of the injurious action of the 
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Figure 5. iability of t e 29- -E12 cells exposed to 10 , 5 f t s cr t f t c lt r f . dorei S
17855 ( ), . dorei PtF 1P5 ( ), . dorei PtF 8 ( ), . dorei t . rei t . i .
dorei PtFSb8 (G), P. dorei PtFC1P2 (H), B. uniformis PtFD3Pch2 (I), B. uniformis PtFSb3P5 (J), P. distasonis PtFD14MH1 (K). The
addition of BHI to cell culture at the tested concentrations was used as control. Bars with the same letter are not statistically
different when compared to control (p > 0.05). Data statistically different for each strain are represented by ** p < 0.01;
*** p < 0.001.
3.5.2. Integrity of HT29-MTX-E12 Cells after Exposure to Bacteroides Species
The different strains of P. dorei were able to adhere and invade the HT-29-MTX-E12
cells, except the two tested strains of B. uniformis that were not able to invade. Therefore,
the impact of colonization by different bacterial species on tight junction integrity was
investigated. The HT-29-MTX-E12 cells were stained with TRICT-phalloidin, a phallotoxin
that binds to actin filaments. This binding allows the observation of any damage that has
occurred in the network of tight junctions as a result of the injurious action of the Bacteroides
species compromising the normal functioning of paracellular communication.
The damage to the tight junctions of HT29-MTX-E12 cells after exposure to P. dorei
strains an P. distasonis was similar and considerable, in co trast with the cells exposed to
B. uniformis that were only slightly a fected. A representative im ge of the disturbed tight
junctions by the colonization of HT29-MTX-E12 cells with the strain P. dorei PtF D16P1 and
B. uniformis PtF D3Pch is illustrated in Figur 6.
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3.6. Genomic Features
Representative circular genome maps for P. dorei, PtFD16P1, B. uniformis PtFD3Pch2
and P. distasonis PtFD14MH1 is shown in Figure 7 (the genome ap of the remaining seven
strains is presented i Figure S3), and their main features are listed in Table 1. The genome
size of P. dorei strains ranged from 5120 Mb to 5880 Mb, and the genome size of P. distasonis
PtFD14MH1 (5066 Mb) is similar to the P. dorei strains (Table 1). The genomes of P. dorei
strains were di tribute along 62 to 153 contigs, with the number of contigs or the strain
of P. distasonis PtFD14MH1 being 8 . B. uniformis PtFD3Pch2 showed a similar genome
size (5457 Mb) to P. dorei strains wherea B. uniformis PtF Sb3P5 showed the lowes gen me
ize, 4393 Mb, assembled in 8 and 21 contigs, respectiv ly. The observed GC% content
for the P. dor i strains ranged between 41.4% and 42.2%. In contrast B. uniformis st ains
and P. distasonis showed the highes GC % content, B. uniformis PtFD3Pch2 achieves 44.1%,
B. uniformis PtF Sb3P5 46.4%, and 45% for P. distasonis PtFD14MH1.
The number of coding genes varied among the P. dorei strains, namely the highest
number was displayed by the strain PtFD1P5 (5184) and PtFSb6, and the lowest by the strain
PtFSb8 (4288) followed by the strain PtFD8M1. The number of coding genes in P. distasonis
PtFD14MH1 was similar to those of P. dorei strains (4240). The strains of B. uniformis
PtFD3Pch2 and PtF Sb5P5 showed 4597 and 3644 coding sequences, respectively.
The distribution of genes by functional categories produced by RAST is summarized in
Table S7. Overall, the number of genes in each functional category did not vary markedly
between the strains. Some of the categories are highlighted. In the category Phages,
Prophages, Transposable elements, and Plasmids, the number of genes in the genomes
of P. dorei PtFD8M1, PtFSb8, and P. distasonis PtFD14MH1 are 47, 48, and 33 respectively.
However, in this category it is found in the genomes of P. dorei PtFD16P1 and PtFSb8,
4 copies of a thiol-activated cytolysin (LLO) of the subsystem of Listeria Pathogenicity
Island LIPI-1. Three copies of this same LLO gene are present in the genomes of strains
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P. dorei PtFD16M14, PtFD8M1, and PtFC1P2. However, no copies of the thiol activated
cytolysin were detected in the genome of P. dorei PtFSb6. The same four copies number of
the thiol-activated cytolysin was found in the genome of B. uniformis PtFD3Pch2. In contrast,
in the genome of B. uniformis PtFSb3P5 just 1 copy of the phosphatidylinositol-specific
phospholipase C (PlcA) was identified. In the genome of P. distasonis PtFD14MH1, two
copies of this type of the thiol-activated cytolysin were identified. The percentage identity
of the identified thiol-activated cytolysins with the listeriolysin O of L. monocytogenes EGD
(lmo0202) is 42.19% for the strain P. dorei PtF D16P1 (20547_PtFD16P1_01393), 39.98% for
B. uniformis PtFD3Pch2 (20551_D3Pch2_00006) and 48.50% for P. distasonis D14MH1.
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ring depicts the coding sequences in both clockwise and anti-clockwise direction. tRNA is depicted as red arrow heads, 
rRNA in orange and tmRNA in royal blue. CRISPR repeats regions are coloured in lime green. GC skewing is shown in 
green and purple, and GC content in black. 
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formis PtFD3Pch2 and PtF Sb5P5 showed 4597 and 3644 coding sequences, respectively. 
The distribution of genes by functional categories produced by RAST is summarized 
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Table 1. Genomic features of the analyzed strains.
Strains Size (Mb) Contigs GC (%) Genes RNAs
. dorei PtFD1P5 5880 153 42.2 5184 77
P. dorei PtFD8 1 5121 62 41.4 4295 76
P. dorei PtFD16P1 5588 101 42.1 4824 75
P. dorei PtFD16M14 5592 110 42.1 4835 77
P. orei PtFSb6 5849 86 42.2 5164 78
P. dorei PtFSb8 5120 72 41.4 4288 74
P. dorei PtFC1P2 5479 83 41.9 4710 76
B. uniformis PtFD3Pch2 5457 8 44.1 4597 59
B. uniformis PtFSb3P5 438 21 46.4 3644 62
P. distasonis PtFD14MH1 5066 81 45 4240 85
The dendogram obtained from the multilocus equencing typing is composed of
8 clusters in total (Figure S4). P. dorei strai s distributed in 6 cluster , and the trains of
B. uniformis and P. distasonis are clustered in two independen clusters. The P. orei strains
cluster d differently with the P. dorei strains used as reference. The referenc strain P. d rei
DSM 17855 is the one that is more distant.
The identification of the poten ial path genicity for the human host, performed with
PathogenFinder 1.1, r veal the prese ce of a collagenase precursor (ABR38775) in the
P. dorei strains PtF D1P5, PtFD16P1, PtFD16M14, PtFC1P2, and B. uniformis PtFD3Pch2. In
P. dorei PtFD16P1 a putative membrane peptidase (ABR39331) was detected. Interestingly,
in the genome of P. distasonis PtFD14MH1 it was found 4 hemolysin related proteins (ABR
43727,ABR 42607, ABR 44661, and ABR 42685), a metal-dependent hydrolase (ABR42910),
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a putative hydrolase (ABR 42975), a N-acetyl-muramoyl-L-alanine-amidase (ABR 44579), a
putative alkaline protease AprF (ABR 41930), a putative aminopeptidase (ABR 42007), and
a putative capsule polysaccharide export protein (ABR42909).
Prophage sequences identified by PHASTER are summarized in Table S8. Only incom-
plete prophages were identified. Among the analyzed bacterial genomes, Flavobacterium
phages were the most common putative phage identified, except for P. dorei PtFD1P5, and
P. distasonis PtFD14MH1. Interestingly, the strain of P. dorei PtF C1P2 carry a prophage DNA
adenine methylase enzyme (Dam) (PHAGE_Flavob_vB_FspS_morran9_1_NC_048836),
and the strains PtFD8M1 and PtFSb8 also show a Flavobacterium phage DNA adenine
methylase enzyme (PHAGE_Flavob_vB_FspM_pippi8_1_NC_048830).
B. uniformis PtFD3Pch2 and PtF Sb3P5 show an endolysin from a Rhodococcus phage
(PHAGE_Rhodoc_Trina_NC_042040), and a holin from a Bacillus phage (PHAGE_Bacill_
Pookie_NC_027394).
Different sequences of CRISPR were detected in the analyzed genomes (Table S9).
Three main CRISPR-Cas types, corresponding essentially to Type IC, Type IIC and Type
VIA were identified.
Table 2 summarizes the results of searching for molecular mimicry in the analyzed
genomes to identify the presence of insulin B chain insB:9–23 peptide mimics (SHLVEALYL
VCGERG) [48], and the two microbial altered peptide ligands (MVWGPDPLYV and RQFG-
PDWIVA) from the natural preproinsulin (ALWGPDPAAA) [50]. A variant of the insB:9–23
peptide (HLLEALYMTYGE) was identified only in the genome of B. uniformis PtF Sb3P5.
In contrast, in all P. dorei genomes and in the genome of the strain B. uniformis PtFD3Pch2,
a modified version of the altered peptide MVWGPDPLYV (MVWGPDNFYV) is observed.
Interestingly, the strain of B. uniformis PtFD3Pch2 showed another variant of this peptide
(MVWSPDPLYV). The P. distasonis PtFD14MH1 showed an altered version of the peptide
ligand RQFGPDWIVA.
Table 2. Sequences of the bacterial mimics for human insulin B:9–23 peptide (SHL) and human natural preproinsulin (ALW).
Human Insulin/Bacterial Peptide Sequence Identity Reference
Human insulin B:9–23 peptide (SHL) SHLVEALYLVCGERG Wildtype [48]
Variant of SHL HLLEALYMTYGE B. uniformis PtFSb3P5 This study
Human Natural preproinsulin (ALW) ALWGPDPAAA Wildtype [49]
Variant of ALW MVWGPDPLYV * Bacteroides fragilis/thetaiotaomicron [49]
Variant of ALW MVWGPDNFYV P. dorei and B. uniformis PtFD3Pch2 This study
Variant of ALW MVWSPDPLYV B. uniformis PtFD3Pch2 This study
Variant of ALW RQFGPDWIVA Clostridium asparagiforme [49]
Variant of ALW RRYGKDWIVA P. distasonis PtFD14MH1 This study
* Bold letters represent amino acids that are different from the reference preproinsulin-derived sequence.
4. Discussion
Nowadays it is clear that geographical location strongly influences the incidence of
T1D [8,10,12,23]. Even in neighboring countries, the intestinal bacterial patterns observed
in children with established T1D does not overlap [17,18,20]. This study confirms that
Portuguese (Algarve region) children with T1D show similar Bacteroides counts, when
compared with control children, both by culture-dependent and qPCR approachs. As it
can be anticipated, the slight difference observed between the counts of Bacteroides by the
culture-dependent approach and qPCR, is clearly associated with the lower recovery of
bacteria in culture medium. Different Bacteroides species were recovered only from T1D
children, namely B. graminisolvens, B. cellulosilyticus, B. finegoldii, B. stercoris, B. eggerthii and
B. fragilis. Diet can modify the composition of the gut microbiota [54–57]. Bacteroides species
are particularly modulated by the accessibility and abundance of dietary fiber [55,58,59],
for example arabinoxylans that are naturally found in all major cereal grains increases
the abundance of B. cellulosilyticus but not of B. ovatus [55,60]. The recommendations
in the guidelines for nutritional management in children and adolescents with diabetes,
stress the importance of consuming a variety of healthy foods, including fruits, vegetables,
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dairy, whole grains, and legumes [61]. However, the individual consumption of these
healthy foods (with a significant load on dietary fiber) will impact the presence of different
Bacteroides species in the gut of T1D children [54,55].
Another interesting finding was the higher recovery in culture of P. distasonis isolates
from the fecal samples of T1D children in comparison with control children. Interestingly,
Falony et al. [62] found an increase in Parabacteroides in individuals with low microbiome
diversity that exhibited a preference for white, low fiber bread, and predominance of
recent amoxicillin treatment. The recent reported molecular mimics of the human insulin
B:9–23 peptide in P. distasonis 33B (from the human gut microbiome) [48] is an important
warning for hidden autoimmune triggers. The genome of P. distasonis PtFD14MH1 did not
show the presence of any variant of insB:9–23, however a variant of the Human Natural
preproinsulin AWL, that is very similar to a previously described variant in C. asparagiforme,
was identified [49]. The role of P. distasonis in host health is still controversial, namely
while Huang et al. [48] reported the stimulation by P. distasonis 33B of the human T cell
clones specific to insB:9–23 and the colonization of the gut of female NOD mice with P.
distasonis 33B stimulate T1D onset, Wang et al. [63] reported that the treatment of obese
mice with live P. distasonis resulted in an increase in the concentration of succinate in
the jejunum, together with the activation of intestinal gluconeogenesis, diminishing food
intake, and amelioration of glucose homeostasis. Other beneficial features of P. distasonis,
is its ability to mitigate obesity-driven colorectal tumorigenesis and attenuate intestinal
inflammation [64,65]. Altogether these findings reveal the controversial nature of the role
of P. distasonis on gut inflammatory diseases. Nevertheless, it is reasonable to anticipate
that such contrasting behavior may be highly strain-specific, and obviously the genetic
background of the host is also a decisive factor. The reason for the higher recovery of P.
distasonis isolates from T1D in comparison to control samples, and how their molecular
mimicry can contribute to the development of T1D, requires additional research.
Repetitive sequence-based PCR banding patterns obtained from both BOX and ERIC
primers, grouped the different Bacteroides species, but no discrimination by origin (cases
and control) was observed. The rep-PCR method is directed to DNA sequences that are
dispersed in the genome of the microorganism, and have been used to find differences
in the bacterial genomes that will help with the discrimination between bacterial isolates,
including the different Bacteroides species [30]. As the majority of bacteria, Bacteroides carry
mobile genetic elements, such as plasmids, conjugative and mobilizable transposons [66].
In the host, these mobilizable genetic elements can enable the exchange of external DNA
from the gut members, which can result in different rep-PCR banding profiles. The lack
of differentiation of the Bacteroides species according to their sampling origin, lead us to
assume that the host condition (T1D or healthy) has no impact on the coevolution of these
Bacteroides species.
T1D children showed a similar ratio of Firmicutes to Bacteroidetes when compared
to control children, but a significant increase in Proteobacteria and Prevotella sp., which
is in contrast with the findings of Murri et al. [17] that observed a significantly higher
ratio of Firmicutes to Bacteroidetes, and higher numbers of Prevotella sp. in healthy children
with no significant differences in the numbers of Proteobacteria. The deviation of data
regarding these bacterial groups can be justified by differences in geographical location
factors [10,12,23]. However, the number of Lactobacillus sp. was impaired in T1D children,
which is in line with the results reported by Murri et al. [17] in children with established
T1D, and with the findings described by Biassoni et al. [67] in children at T1D onset, as well
as with findings using rodent models, namely in bio-breeding diabetes prone mice [68] and
streptozotocin T1D rat model [69,70].
All tested P. dorei and P. vulgatus strains were able to grow in the presence of porcine
gastric mucin (1% [w/v]), but in a limited way when compared with their growth in
the presence of glucose (0.5%, w/v) or in complex medium (BHI + H). The ability to
break mucin, evidenced by amidoblack staining, was confirmed for all tested strains.
Bacteroides species are recognized by their ability to degrade dietary fiber and host intestinal
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mucin [57,71]. Taking this into account, and knowing that hyperglycemia affects the
intestinal mucus layer allowing a diminished microbiota-epithelial distance [72], P. dorei, P.
vulgatus and other Bacteroidetes members in T1D gut may contribute to a disturbed mucus
layer, therefore facilitating bacterial infiltration.
The ability to adhere to HT-29-MTX cells was similarly observed for all tested strains
of P. dorei, B. uniformis and the strain of P. distasonis PtFD14MH1. The ability of different
Bacteroides species and P. distasonis isolates, collected from a healthy donor for fecal micro-
biota transplantation (FMT), to adhere to the intestinal epithelial cells HT-29 and Caco-2
(non-mucus secreting cell) was recently reported [65]. The authors observed that the three
isolates of B. caccae, and among the six isolates of P. distasonis only one was able to adhere to
HT-29 and Caco-2 cells [65]. Our contrasting findings can be explained by the differences
between the strains and the cell line tested (a mucus secreting cell).
In this study it was observed that the ability to invade HT-29-MTX cells was different
between species and strains, where the highest ability to invade was achieved by P. dis-
tasonis PtFD14MH1 followed by P. dorei strains PtF D16P1 and PtF Sb8. The B. uniformis
strains were not able to invade HT-29-MTX cells. A severe damage to the tight junctions of
HT29-MTX cells after exposure to P. dorei strains and P. distasonis was observed, in contrast
with the B. uniformis strains that cause a minor disturbance. To the best of our knowledge,
this is the first study that reports the ability of Bacteroides species and Parabacteroides to
invade mucus secreting cells. Different number of copies of the thiol-activated cytolysin
(Listeriolysin O, LLO) of the subsystem of Listeria Pathogenicity Island LIPI-1 were identi-
fied in the genome of the P. dorei strains, B. uniformis and P. distasonis PtFD14MH1, except
in the strain P. dorei PtFSb6. It is known that LLO, a pore-forming toxin is able to exert
lytic activity in different types of cells, including the intestinal epithelial cell Caco-2 [73–75].
The presence of pore-forming toxins in the genome of P. dorei was recently described in
the strain P. dorei CL03T12C01, including a Hly-III homologue [76]. The transepithelial
electrical resistance (TEER) of Caco-2 cells decreases very rapidly (30s) after exposure to
LLO at 1 µM [75]. A similar impairment of TEER values in the HT-29/B6 human colon cells
was previously reported [77]. The decline in TEER values reported by Cajnko et al. [75] was
associated to pore formation and to the disturbance of the tight junction protein claudin-1.
Several bacteria, namely group A Streptococcus and S. agalactiae are able to increase intesti-
nal permeability by disrupting tight junctions, which allows their paracellular passage [78].
The work of Vieira et al. [79] evidenced the ability of Enterococcus gallinarum to break the
gut barrier being translocated to the liver, spleen and mesenteric lymph nodes, leading
to the development of autoimmunity. The extent to which the thiol-activated cytolysins
found in our strains contributes to the invasion of intestinal epithelial cells and disruption
of tight junctions is one of our current research lines.
It was reported that the 1E6 human CD8+T cell clone, which intermediates the dam-
age of β cells by recognizing the major HLA-A*0201-restricted, preproinsulin signal pep-
tide (ALWGPDPAAA15–24, AWL) is able to recognize a massive number of different pep-
tides [80]. Moreover, insulitic lesions in T1D patients show a significant occupancy with
CD8+ T cells that recognize HLA-A*0201–ALWGPDPAAA [81]. The variants of the pre-
proinsulin signal peptide AWL with sequence MVWGPDPLYV and RQFGPDWIVA were
identified in B. fragilis/thetaiotaomicron and C. asparagiforme, and this latter variant was
able to activate the 1E6 T cell with higher potency than the ALW sequence highlighting
the potential development of autoimmunity by the T- cell cross-reactivity with bacterial
derived peptides [49]. The results of the molecular mimicry search in the present study
showed the presence of variants of the human natural preproinsulin ALW in the strains of P.
dorei, B. uniformis and P. distasonis. It is important to highlight that P. distasonis PtFD14MH1
carries a variant similar to the one found in C. asparagiforme (RRYGKDWIVA); in contrast
the strains of P. dorei and B. uniformis carry a variant similar to the one found in B. frag-
ilis/thetaiotaomicron (MVWGPDNFYV). Intriguing, only the strain of B. uniformis PtFSb3P5
showed a variant of the human insulin B:9–23 peptide (HLLEALYMTYGE, SHL). The
reported variant of the SHL in P. distasonis 33B (RILVELLYLVCSEYL) is able to promote an
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immune response to the endogenous insB:9–23, and the exposure of female NOD mice to
P. distasonis mimic peptide during the gut microbiota maturing precipitated the onset of
T1D [49]. Our findings, together with the others discussed, empower the hypothesis that
common gut bacteria may injure the gut integrity, allowing for bacterial dissemination and
eliciting an immune response that, in susceptible hosts, may trigger autoimmunity [82].
Several studies have reported the beneficial role of different Lactobacillus species on
delaying the development of T1D or reducing its complications, using mice models [83–86]. In
the current study the fecal samples of T1D children showed lower numbers of Lactobacillus
spp. in comparison with control children, and such findings were also observed in fecal
samples of Spanish T1D children [17]. Interestingly, we observed that the invasive ability of
P. dorei and P. distasonis PtFD14MH1, using HT-29-MTX cells was impaired in the presence
of L. casei DSM 20011, except for the strain P. dorei PtFD16P1. Probiotics (non-pathogenic
microorganisms that are capable of protecting and promoting the health status of the
host, such as Lactobacillus spp.) can act against pathogens through different mechanisms,
namely by producing antibacterial substances like bacteriocins that prevent their replication,
competition for scarce nutrients in the host, anti-adhesive and anti-invasive action, and
competitive exclusion by obstructing the adherence of pathogens to host cell binding
sites [87,88]. One of the great benefits that L. casei strains can possibly exert against the
invasion ability of our tested strains of P. dorei and P. distasonis is its known capacity to
promote the abundance of tight junction proteins and mucin [87,89]. The inability of L. casei
DSM 20011 to inhibit the invasion of strain P. dorei PtFD16P1 requires further investigation.
The viability of HT-29-MTX-E12 cells was impaired by the exposure to the secretome of
several P. dorei strains, the strains of B. uniformis and the P. distasonis PtF D14MH1. Recently
the impact of the secretome of 157 gut bacteria on the growth rates of 5 colorectal cancer
cell lines (CRC), including HT-29 was evaluated [90], and among these 157 gut bacteria,
12 belonged to the genus Bacteroides comprising the species P. dorei, B. eggerthii, B. fragilis,
B. massiliensis, and B. ovatus. The effect of the Bacteroides species on cell growth of HT-29
cell line varied from an enhancement to a decline [90]. The negative impact of Bacteroides
species on the growth of the CRC lines was attributed to the action of lipoproteins at the
bacterial surface that have a high affinity for cobalamin, confiscating it from the culture
medium, making this crucial vitamin inaccessible to the human cells, hence impairing their
growth [90,91]. We can anticipate that besides the role of lipoproteins, other components
of the secretome of our strains may be involved in the impairment of the viability of
HT-29-MTX-E12 cells, namely the bacterial protease arsenal, which remains to be studied.
5. Conclusions
The recovery of Bacteroides species from the fecal samples of T1D and control children
allowed us to expand our knowledge about their potential contribution to elicit adverse
effects in susceptible hosts such as T1D children. The reason for the higher recovery of P.
distasonis from T1D fecal samples demands additional investigation. It is noteworthy the
observed invasion ability and capacity of some P. dorei strains and P. distasonis PtFD14MH1
to damage the tight junctions of the intestinal epithelial cells. The depletion of Lactobacillus
spp. on the gut microbiota of T1D children was noticed, and its ability to inhibit the
invasion ability of the tested strains was remarkable. These data together with other
previous reports, evidence the continued efforts that have to be made to find the necessary
balance between the gut microbiota of T1D children.
Our data also highlights the need to explore the contribution of the molecular mimicry,
identified in the tested strains, to the development of autoimmunity, and offer new oppor-
tunities to find tools that can prevent and treat this disease that has such high prevalence
and causes severe comorbities in medium to long term.
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